Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Premenopausal Breast Cancer
Interventions: DRUG: Elacestrant|DRUG: Triptorelin
Sponsor: SOLTI Breast Cancer Research Group